Cannabis Research

A Clarence cigarette manufacturer says it has expanded its cannabis research program. The 22nd Century Group said its wholly owned subsidiary, Botanical Genetics, has launched a number of new research projects to develop proprietary cannabis strains that have medical and agricultural uses. Company officials estimate the markets for medical marijuana and industrial hemp – which […]

by

CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and cannabis research, announced today that the Company’s wholly-owned subsidiary, Botanical Genetics LLC, has expanded its cannabis research program to include multiple new research projects in support of its core mission, which is to develop […]

by

CLARENCE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction and cannabis research, announced today that the Company’s wholly-owned subsidiary, Botanical Genetics LLC, has expanded its cannabis research program to include multiple new research projects in support of its core mission, which is to develop […]

by

The US Drug Enforcement Agency (DEA) decided to reject a petition that asked them to reclassify marijuana, leaving it in the Schedule 1 (most restricted) category of controlled substances with “no currently accepted medical use”, as NPR and other outlets reported Wednesday. But one aspect of the decision could actually open the door for medical marijuana […]

by

Boulder-based BDS has launched the first consumer research survey dedicated to cannabis consumers. “The number one rule for all businesses is, ‘Know your customer,’” said BDS Founder and CEO Roy Bingham. “As the cannabis industry’s leading market research firm, we decided to invest in serious consumer research on behalf of the industry.” Linda Gilbert, a […]

by

Boulder-based BDS has launched the first consumer research survey dedicated to cannabis consumers. “The number one rule for all businesses is, ‘Know your customer,’” said BDS Founder and CEO Roy Bingham. “As the cannabis industry’s leading market research firm, we decided to invest in serious consumer research on behalf of the industry.” Linda Gilbert, a […]

by

Wanted: Someone to grow marijuana for the federal government. Benefits: A contract likely worth millions and the chance to enable medical research. Requirements: Ability to deal with the costs and regulations that come with growing an illegal drug for the federal government. For more than four decades, the University of Mississippi has had an exclusive […]

by

Two groups studying the cannabis economy say legalizing recreational marijuana in California will provide a $1.6 billion boost in revenue from expanded retail marijuana sales. The projections on California’s Proposition 64 legalization measure in November come from two firms with a vested interest in expanding the marijuana business. The market study was completed by New […]

by

by Rick Thompson In the wake of the DEA’s refusal to move cannabis from the list of the most addictive and non-medical drugs,TIME Magazine sought opinions on the future of canna-science from experts currently conducting research with marijuana. The casual statements about the safety of cannabis made by the experts are noteworthy. Scientists argue that […]

by

Despite the recent DEA decision to keep cannabis classified as a Schedule 1 substance with no medicinal value, Washington State is moving forward with their plans to prove the plant’s value through solid, scientific research. The state has officially announced its plans to move ahead with granting marijuana research licenses that will allow license holders to […]

by